Afatinib/osimertinibTreatment failure: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70778-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：28 / 28

相关论文

共 50 条

[1] Afatinib/amrubicin/oxycodoneVarious toxicities: 3 case reports
Reactions Weekly, 2017, 1664 (1) : 25 - 25
[2] Afatinib/gefitinib/osimertinibDrug resistance: 3 case reports
Reactions Weekly, 2019, 1773 (1) : 18 - 18
[3] Afatinib/erlotinibRash, paronychia and diarrhoea: 3 case reports
Reactions Weekly, 2018, 1694 (1) : 21 - 21
[4] Afatinib/erlotinibErosive pustular dermatosis of the scalp: 3 case reports
Reactions Weekly, 2025, 2045 (1) : 22 - 22
[5] Afatinib/gefitinibDiarrhoea, stomatitis and skin disorders: 3 case reports
Reactions Weekly, 2020, 1789 (1) : 16 - 16
[6] Afatinib/ciprofloxacin/tetracyclineFolliculitis decalvans and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1980 (1) : 21 - 21
[7] Afatinib/bevacizumabDiarrhoea, jaw osteonecrosis and cutaneous ulcer: 3 case reports
Reactions Weekly, 2021, 1884 (1) : 26 - 26
[8] Afatinib/bevacizumab/erlotinibAcneiform dermatitis, proteinuria and stomatitis: 3 case reports
Reactions Weekly, 2023, 1952 (1) : 32 - 32
[9] Afatinib/bevacizumabAcquired resistance: 8 case reports
Reactions Weekly, 2018, 1726 (1) : 20 - 20
[10] Afatinib/poziotinibVarious toxicities: 6 case reports
Reactions Weekly, 2018, 1721 (1) : 17 - 17

← 1 2 3 4 5 →